Clinical trial
Radiation Sensitivity, DNA Repair, and Second Cancers.
NCT00949052 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiation Sensitivity, DNA Repair, and Second Cancers.
- Lead sponsor
- Vanderbilt-Ingram Cancer Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2009
- Completion date
- February 28, 2018
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer